Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177242
Status:
COMPLETED
Last Update Posted:
2016-01-18
First Post:
2005-09-12
Brief Title:
Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
04-027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Pittsburgh
Lead Sponsor Class:
OTHER
Responsible Party:
Nathan Bahary MD
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |